Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
Indian J Lepr
;
1988 Jan; 60(1): 90-2
Artículo
en Inglés
| IMSEAR
| ID: sea-55423
ABSTRACT
A thirty-one year old male patient was diagnosed and treated for a pure or better primary neuritic case of leprosy with dapsone (100 mg daily for 2 years) and rifampicin (600 mg daily for 6 months). From the very outset, the patient did not show any improvement; on the top of it, he subsequently, developed a cutaneous patch, which on histopathological examination, revealed classical features of BT leprosy. Acid-fast bacilli were absent both in skin slit smear and histologic section. A primary resistance to both dapsone and rifampicin, even in paucibacillary patient, is speculated.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Rifampin
/
Humanos
/
Masculino
/
Farmacorresistencia Microbiana
/
Lepra Tuberculoide
/
Adulto
/
Dapsona
/
Quimioterapia Combinada
/
Mycobacterium leprae
Idioma:
Inglés
Revista:
Indian J Lepr
Asunto de la revista:
Tropical Medicine
Año:
1988
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS